Biotech hub outsources R&D to marketplace provider
LabCentral signs outsourced R&D provider Science Exchange, enabling access to more than 2,500 qualified scientific service providers
List view / Grid view
News
New app replaces ultrasound to measure heart health
Engineers have demonstrated that the camera on your smartphone can noninvasively provide detailed information about heart health...
Zika virus shown to kill brain cancer stem cells
Research published in The Journal of Experimental Medicine suggests potential treatment for glioblastoma
Antidepressant could slow Parkinson’s disease
Nortriptyline, which has been used to treat depression has been found to stop the growth of abnormal proteins on the brain...
Multichannel pipetting to make you smile
INTEGRA is making multichannel pipetting quicker and easier than ever before...
FDA grants orphan drug status to Cellect’s ApoGraft
The FDA has granted orphan drug designation for ApoGraft for the prevention of acute and chronic graft versus host disease...
Study shows contrasting cognitive effects of psychiatric drugs
A long-term study has found that low cumulative exposure to benzodiazepine does not affect cognition in schizophrenia...
Methodology developed for assessing the value of new medicines
The Advance Value Framework has addressed the pitfalls of current approaches assessing the value of new medicines...
BioPharm America™ global partnering event gives attending companies direct contact with biotech innovation, pharma executives and funding sources
This month, 800+ life science leaders will gather in Boston for the tenth annual BioPharm America™ life science partnering event, September 26–27 at the Sheraton Boston Hotel...
Asthma medicine halves risk of Parkinson’s
Researchers have found that asthma medicine can halve a patient's risk of developing Parkinson's disease...
FDA approves Mylotarg for treatment of acute myeloid leukemia
The FDA has approved Mylotarg for the treatment of adults with newly diagnosed acute myeloid leukaemia whose tumours express the CD33 antigen...
Novartis announces new CEO
Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018.
Beta blockers have positive effect in pulmonary arterial hypertension
A team of researchers have found that a common heart disease medication may help treat lung disease...
Pharma businesses failing to report data breaches
The real extent of the pharma sector’s problem with data breaches has been revealed...
FDA approves CAR T cell therapy for children with leukaemia
The FDA has approved CAR T cell therapy for treatment of children with acute lymphoblastic leukemia...
